Ian Hambleton
Ian Hambleton
About me
download biosketch & CV
work history
committee work
contact me
Projects
Publications
COVID-19
CaribData
"Hemoglobins/therapeutic use"
Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Sickle Cell Disease (SCD) is a genetic condition which manifests as altered hemoglobin (Hb) protein that can aggregate under hypoxic …
Kim R. Quimby
,
Ian R. Hambleton
,
R. Clive Landis
Cite
DOI
Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Sickle Cell Disease (SCD) is a genetic condition which manifests as altered hemoglobin (Hb) protein that can aggregate under hypoxic …
Kim R. Quimby
,
Ian R. Hambleton
,
R. Clive Landis
Cite
DOI
Cite
×